All the IT systems of the European Medicines Agency (EMA) will be temporarily unavailable from 6 am U.K. time on Saturday, April 16 to 6 am Sunday the 17th (U.K. time) due to essential maintenance, according to an EMA announcement released yesterday.
All the IT systems of the European Medicines Agency (EMA) will be temporarily unavailable from 6 am U.K. time on Saturday, April 16 to 6 am Sunday the 17th (U.K. time) due to essential maintenance, according to an EMA announcement released yesterday.
“During these 24 hours, it will not be possible to access the EMA public website, or any other EMA-hosted website or online application, including the systems used to send and receive applications for EMA regulatory procedures. Normal service will resume on April 17,” the agency noted.
Emails sent to EMA email addresses during this period will be queued and delivered to recipients on the 17th. The EMA product emergency hotline and phone number for notifying suspected quality defects or product recalls will operate as usual. While the EMA public website is unavailable, a holding page will be displayed with details of these emergency numbers.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
2 Commerce Drive
Cranbury, NJ 08512